Table 2.
Sensitivity and specificity of the PML score
| Patients with liver diseases | Sensitivity | Specificity |
|---|---|---|
| (N = 94) | Positive/n (%) | Negative/N-n (%) |
| PBC (n = 26) | 22/26 (84.6) | 61/68 (89.7) |
| PSC (n = 20) | 1/20 (5) | 46/74 (62.2) |
| NASH (n = 11) | 1/11 (9.1) | 55/83 (66.3) |
| Viral Hepatitis (n = 37) | 5/37 (13.5) | 33/57 (57.9) |
| • Chronic HBV infection (n = 25) | 4/25 (16) | 44/69 (63.8) |
| • Chronic HCV infection (n = 12) | 1/12 (8.3) | 54/82 (65.9) |
PML: promyelocytic leukemia protein; PBC: primary biliary cholangitis; PSC: primary sclerosing cholangitis; NASH: non-alcoholic steatohepatitis; HBV: hepatitis B virus; HCV: hepatitis C virus. N = the total number of patients; n = the number of patients in each specific liver disease.